Actomyosin-Based Nanodevices for Sensing and Actuation: Bridging Biology and Bioengineering
Biosensors · 2025
DOI: 10.3390/bios15100672 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biosensors, 2025. Verfasst von Nicolas M Brunet und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychology, California State University, San Bernardino, CA 92407, USA. Hauptthemen laut MEDLINE: Actomyosin, Biosensing Techniques, Nanotechnology, Bioengineering. Die Arbeit nennt 221 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIH HHS, U.S. National Institutes of Health NHLBI.
Abstract (Originalsprache)
The actomyosin complex—nature’s dynamic engine composed of actin filaments and myosin motors—is emerging as a versatile tool for bio-integrated nanotechnology. This review explores the growing potential of actomyosin-powered systems in biosensing and actuation applications, highlighting their compatibility with physiological conditions, responsiveness to biochemical and physical cues and modular adaptability. We begin with a comparative overview of natural and synthetic nanomachines, positioning actomyosin as a uniquely scalable and biocompatible platform. We then discuss experimental advances in controlling actomyosin activity through ATP, calcium, heat, light and electric fields, as well as their integration into in vitro motility assays, soft robotics and neural interface systems. Emphasis is placed on longstanding efforts to harness actomyosin as a biosensing element—capable of converting chemical or environmental signals into measurable mechanical or electrical outputs that can be used to provide valuable clinical and basic science information such as functional consequences of disease-associated genetic variants in cardiovascular genes. We also highlight engineering challenges such as stability, spatial control and upscaling, and examine speculative future directions, including emotion-responsive nanodevices. By bridging cell biology and bioengineering, actomyosin-based systems offer promising avenues for real-time sensing, diagnostics and therapeutic feedback in next-generation biosensors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychology, California State University, San Bernardino, CA 92407, USA.
- Department of Physics, Florida State University, Tallahassee, FL 32306, USA.
- Department of Biological Science, Florida State University, Tallahassee, FL 32306, USA.
ORCID-Profile: Nicolas M Brunet, Peng Xiong, Prescott Bryant Chase
Förderung
- NHLBI NIH HHS
- NIH HHS
- U.S. National Institutes of Health NHLBI
Zitieren
APA
Brunet, N. M., Xiong, P., & Chase, P. B. (2025). Actomyosin-Based Nanodevices for Sensing and Actuation: Bridging Biology and Bioengineering. Biosensors. https://doi.org/10.3390/bios15100672
Vancouver
Brunet NM, Xiong P, Chase PB. Actomyosin-Based Nanodevices for Sensing and Actuation: Bridging Biology and Bioengineering. Biosensors. 2025. doi:10.3390/bios15100672
BibTeX
@article{Brunet2025,
author = {Brunet, Nicolas M and Xiong, Peng and Chase, Prescott Bryant},
title = {Actomyosin-Based Nanodevices for Sensing and Actuation: Bridging Biology and Bioengineering},
journal = {Biosensors},
year = {2025},
doi = {10.3390/bios15100672}
}
EUVIMED